Shared genetic predisposition in Peripartum and dilated cardiomyopathies

New England Journal of Medicine

Volumn 374, Issue 3, 2016, Pages 233-241

  Ware, James S ^a,e,f   Li, Jian ^b   Mazaika, Erica ^a,f   Yasso, Christopher M ^a   De Souza, Tiffany ^b   Cappola, Thomas P ^b   Tsai, Emily J ^g   Hilfiker Kleiner, Denise ⁱ   Kamiya, Chizuko A ^j   Mazzarotto, Francesco ^e   Cook, Stuart A ^f,k   Halder, Indrani ^c   Prasad, Sanjay K ^e,f   Pisarcik, Jessica ^c   Hanley Yanez, Karen ^c   Alharethi, Rami ^l   Damp, Julie ^m   Hsich, Eileen ⁿ   Elkayam, Uri ^o   Sheppard, Richard ^p   Kealey, Angela ^q   Alexis, Jeffrey ^h   Ramani, Gautam ^s   Safirstein, Jordan ^u   Boehmer, John ^d   Pauly, Daniel F ^w   Wittstein, Ilan S ^t   Thohan, Vinay ^x   Zucker, Mark J ^v   Liu, Peter ^r   Gorcsan, John ^c   McNamara, Dennis M ^a   Seidman, Christine E ^a   Seidman, Jonathan G ^a,c   Arany, Zoltan ^b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g Columbia University ^*  (United States)

^h UNIVERSITY OF ROCHESTER   (United States)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^l INTERMOUNTAIN MEDICAL CENTER   (United States)

^m VANDERBILT UNIVERSITY   (United States)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p MCGILL UNIVERSITY   (Canada)

^q UNIVERSITY OF CALGARY   (Canada)

^r UNIVERSITY OF TORONTO   (Canada)

^s UNIVERSITY OF MARYLAND   (United States)

^t JOHNS HOPKINS HOSPITAL   (United States)

^u Morristown Hospital   (United States)

^v NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^w TRUMAN MEDICAL CENTER   (United States)

^x WAKE FOREST UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; NONSENSE MUTATION; PERIPARTUM CARDIOMYOPATHY; PREVALENCE; PRIORITY JOURNAL; RNA SPLICING; CARDIOMYOPATHY; CASE CONTROL STUDY; CHEMISTRY; DNA SEQUENCE; GENETICS; HEART STROKE VOLUME; MUTATION; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATION;

CONNECTIN; ISOPROTEIN; TTN PROTEIN, HUMAN;

ADULT; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CONNECTIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEIN ISOFORMS; SEQUENCE ANALYSIS, DNA; STROKE VOLUME;

EID: 84988366010     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1505517     Document Type: Article

References (31)

1. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011;58:659-70.
2. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.
3. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 2014;11:364-70.
4. Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485:333-8.
5. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600.
6. Herman DS, Lam L, Taylor MR, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012;366:619-28.
7. Horne BD, Rasmusson KD, Alharethi R, et al. Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet 2011;4:359-66.
8. Ntusi NB, Wonkam A, Shaboodien G, Badri M, Mayosi BM. Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J 2011;101:394-8.
9. Massad LS, Reiss CK, Mutch DG, Haskel EJ. Familial peripartum cardiomyopathy after molar pregnancy. Obstet Gynecol 1993;81:886-8.
10. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 1995;129:421-2.
11. Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med 1963;111:651-5.
12. Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013;108:366.
13. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014;35:2 165-73.
14. Morales A, Painter T, Li R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176-82.
15. Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders: results from the Japanese nationwide survey of peripartum cardiomyopathy. Circ J 2011;75:1975-81.
16. McNamara DM, Starling RC, Cooper LT, et al. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol 2011;58:1112-8.
17. McNamara D, Damp J, Elkayam U, Hsich E, Ewald G, Cooper L. Myocardial recovery at six months in peripartum cardiomyopathy: results of the NHLBI multicenter IPAC study. Circulation 2013;128:A12898. abstract.
18. McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the Investigations of Pregnancy Associated Cardiomyopathy (IPAC) study. J Am Coll Cardiol 2015;66:905-14.
19. Roberts AM, Ware JS, Herman DS, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 2015;7:270ra6.
20. Van der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 2013;11:11.10.1-11.10.33.
21. Cingolani P, Platts A, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012;6:80-92.
22. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010;26:2069-70.
23. Pugh TJ, Kelly MA, Gowrisankar S, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014;16:601-8.
24. Goland S, Modi K, Hatamizadeh P, Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail 2013;19:214-8.
25. Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013;62:1715-23.
26. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352:362-72.
27. Giliberto F, Radic CP, Luce L, Ferreiro V, de Brasi C, Szijan I. Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization. J Neurol Sci 2014;336:36-41.
28. Cheng VE, Prior DL. Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy. Heart Lung Circ 2013;22:677-81.
29. Toib A, Grange DK, Kozel BA, Ewald GA, White F V, Canter CE. Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women. J Am Coll Cardiol 2010;55:408-10.
30. Bello NA, Arany Z. Molecular mechanisms of peripartum cardiomyopathy: avascular/hormonal hypothesis. Trends Cardiovasc Med 2015;25:499-504.
31. Halkein J, Tabruyn SP, Ricke-Hoch M, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123:2143-54.